In the News ORGANOPlus Showcases Oncology Validation Platform at BIO-Europe Spring 2026 Mar 31, 2026 ORGANOPlus presented its tumor microenvironment–based organ-on-a-chip platform at BIO-Europe Spring 2026, enabling human-relevant validation of oncology candidates.Partnering discussions confirmed growing demand for predictive, human-derived evaluation systems beyond traditional models. PreviousAACR 2026 Selects ORGANOPlus’ Microbiome Oncology Candidate OP820 for Poster PresentationNextORGANOPlus Participates in Inha University Hospital Open Lab “Connect Day” Networking Forum Back to list
